| S.No. |
Product Name |
Strengths |
Pack Style |
Current Status |
Dossier Timelines (6M Stability) |
| 1 |
5 Fluorouracil Injection |
250mg / 500mg |
5 ml amber colored 5 ampoules in a carton |
Available |
Available |
| |
10 ml amber colored 5 ampoules in a carton |
Available |
Available |
| 2 |
Bortezomib Injection (Lyophilized) |
1mg |
Availble Soon |
Available |
Available |
| 2mg |
Availble Soon |
Available |
Available |
| 3.5mg |
10 ml vial in a monocarton |
Available |
Available |
| 3 |
Carboplatin Injection |
150mg |
20 ml vial in a monocarton |
Available |
Available |
| 450mg |
50 ml vial in a monocarton |
Available |
Available |
| 4 |
Cisplatin Injection |
10mg |
10 ml amber colored vial in a monocarton |
Available |
Available |
| 50mg |
50 ml amber colored vial in a monocarton |
Available |
Available |
| 5 |
Cyclophosphamide Injection (Lyophilized) |
200mg / 500mg / 1000mg |
Availble Soon |
Under development |
Q2 |
| 6 |
Docetaxel Injection |
20mg |
Combi pack (10 ml vial with WFI) |
Available |
Available |
| 80mg |
Combi pack (10 ml vial with WFI) |
Available |
Available |
| 120mg |
Combi pack (10 ml vial with WFI) |
Available |
Available |
| 7 |
Doxorubicin Injection (Lyophilized) |
10mg |
10 ml vial in a monocarton |
Available |
Available |
| 20mg |
30 ml vial in a monocarton |
Available |
Available |
| 8 |
Epirubicin Injection (Lyophilized) |
10mg |
Availble Soon |
Under development |
Q3 |
| 50mg |
Availble Soon |
Under development |
Q3 |
| 100mg |
Availble Soon |
Under development |
Q3 |
| 9 |
Etoposide Injection |
10mg |
Availble Soon |
Under development |
Q3 |
| 10 |
Gemcitabine Injection (Lyophilized) |
200mg |
10 ml vial in a monocarton |
Available |
Available |
| 1000mg |
50 ml vial in a monocarton |
Available |
Available |
| 11 |
Irinotecan Injection |
40mg |
2 ml amber colored vial in a monocarton |
Available |
Available |
| 100mg |
5 ml amber colored vial in a monocarton |
Available |
Available |
| 12 |
L- Asparaginase Injection (Lyophilized) |
5000 IU |
Availble Soon |
Under development |
Q3 |
| 10000 IU |
Availble Soon |
Under development |
Q3 |
| 13 |
Leucovorin Calcium Injection |
15mg |
Availble Soon |
Under development |
Q3 |
| 50mg |
Availble Soon |
Under development |
Q3 |
| 14 |
Methotrexate Injection |
15mg |
Availble Soon |
Under development |
Q2 |
| 50mg |
Availble Soon |
Under development |
Q2 |
| 500mg |
Availble Soon |
Under development |
Q2 |
| 1000mg |
Availble Soon |
Under development |
Q2 |
| 15 |
Oxaliplatin Injection (Lyophilized) |
50 mg |
30 ml vial in a monocarton |
Available |
Available |
| 100mg |
50 ml vial in a monocarton |
Available |
Available |
| 16 |
Paclitaxel Injection |
30mg |
5 ml vial in a monocarton |
Available |
Available |
| 100mg |
16.7 ml vial in a monocarton |
Available |
Available |
| 300mg |
50 ml vial in a monocarton |
Available |
Available |
| 17 |
Pemetrexed Injection (Lyophilized) |
100mg |
10 ml vial in a monocarton |
Available |
Available |
| 500mg |
30 ml vial in a monocarton |
Available |
Available |
| 18 |
Topotecan Injection (Lyophilized) |
4mg |
Availble soon |
Under development |
Q2 |
| 19 |
Zoledronic Acid Injection (Lyophilized) |
4mg |
5 ml vial in a monocarton |
Available |
Available |
